Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prodrugs of A2B adenosine receptor antagonists

Prodrugs of A2B adenosine receptor antagonists

US Patent 8143249 · Granted Mar 27, 2012

Estimated economic value: $132,735,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for treatment of viral infections2025
1′-cyano nucleoside analogs and uses thereof2025
1′-cyano nucleoside analogs and uses thereof2025
Toll like receptor modulator compounds2025
Compounds and methods for treatment of viral infections2025
Substituted 6-azabenzimidazole compounds2025
Substituted 6-azabenzimidazole compounds2025
Compounds and methods for treatment of viral infections2024
Phospholipid compounds and methods of making and using the same2024
Substituted eneoxindoles and uses thereof2024
Cannabinoid receptor type 2 (CB2) modulators and uses thereof2024
1′-cyano nucleoside analogs and uses thereof2024